Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation

Journal of Nuclear Medicine

Volumn 38, Issue 8, 1997, Pages 1310-1315

  Van Der Laken, Conny J ^a   Boerman, Otto C ^b   Oyen, Wim J G ^b   Van De Ven, Marjo T P ^b   Scott Edwards, D ^b   Barrett, John A ^b   Van Der Meer, Jos W M ^b   Frans, H M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Biodistribution; Chemotactic peptides; Imaging; Infection; Inflammation

Indexed keywords

CHEMOTACTIC PEPTIDE; FORMYLMETHIONYLLEUCYLPHENYLANANYLLYSINEHYDRAZINONICOTINAMIDE TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ABSCESS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT; SCINTISCANNING; SOFT TISSUE INFECTION;

ABSCESS; ANIMALS; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; ESCHERICHIA COLI INFECTIONS; FEMALE; INFLAMMATION; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; OLIGOPEPTIDES; ORGANOTECHNETIUM COMPOUNDS; RABBITS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TECHNETIUM; ZYMOSAN;

EID: 0030878957     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fischman AJ, Pike MC, Kroon D, et al. Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J Nuct Med 1991;32:483-491.
2. Babich JW, Graham W, Barrow SA, et al. Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit. J Nucl Med 1993;34:2176-2181.
3. van der Laken CJ, Boerman OC, Oyen WJG, et al. Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. Eur J Nucl Med 1995;22:1249-1255.
4. Signore A, Chianelli M, Toscano A, et al. A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studies. Nucl Med Commun 1992;13:713-722.
5. Hay RV, Skinner RS, Newman OC, et al. Nuclear imaging of acute inflammatory lesions with recombinant human interleukin-8 [J. J Nucl Med 1993;34:104P.
6. Corstens FHM, van der Meer JWM. Chemotactic peptides: new locomotion for imaging of infection? J Nucl Med 1991;32:491-494.
7. Ward PA, Lepow IH, Newman LJ. Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol 1968;52:725-736.
8. Schiffmann E, Corcoran BA, Wahl SM. N-formylmethionyl peptides as chemoattractants for leukocytes. Proc Natl Acad Sei USA 1975;72:1059-1062.
9. Niedel J, Wilkinson S, Cuatrecasas P. Receptor-mediated uptake and degradation of 125l-chemotactic peptide by human neutrophils. J Biol Chem 1979;254:10700-10706.
10. Williams LT, Snyderman R, Pike MC, Lefkowitz RJ. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sei USA 1977:74:1204-1208.
11. Babich JW, Solomon H, Pike MC, et al. Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. J Nucl Med 1993;34:1964-1974.
12. Babich JW, Higgins JD, Abrams MJ, et al. Infection imaging with radiolabeled chemotactic peptides: relationship between receptor affinity and infection [J. J Nucl Med 1994;35:44P.
13. Fischman AJ, Babich JW, Barrow SA, et al. Detection of acute bacterial infection within soft tissue injuries using a WmTc-labeled chemotactic peptide. J Trauma 1995;38:223-227.
14. Fischman AJ, Babich JW, Rubin RH. Infection imaging with technetium-99m-labeled chemotactic peptide analogs. Semin Nucl Med 1994;24:154-168.
15. Fischman AJ, Babich JW, Barrow SA, Rubin RH. Detection of focal infection in non-human primates with a Tc-99m-labeled chemotactic peptide [J. / Nucl Med 1995;36:205P.
16. Vegad JL, Lancaster MC. Histological study of increased vascular permeability in the sheep in turpentine-induced inflammation of skin and pleura. Indian J Exp Biol 1973;! 1:494-497.
17. Svanes K. Diphasic increase of vascular permeability in turpentine-induced inflammation in skin and musculature of mice. Ada Pathol Microbiol Scand A 1971;79: 335-344.
18. Carter EA, Tompkins RG, Babich JW, Fischman AJ. Accumulation of Tc-99m chemotactic peptides in chronic intestinal inflammation [J. ./ Nucl Med 1996;37:239P.
19. Carter EA, Tompkins RG, Babich JW, Fischman AJ. Severe trauma increases Tc-99m chemotactic peptide accumulation in lung: comparison with In-111 WBCs [J. J Nucl Med 1996;37:240P.
20. Lefkowitz JB. Essential fatty acid deficiency inhibits the in vivo generation of leukotriene B4 and suppresses levels of resident and elicited leukocytes in acute inflammation. J Immunol 1988;140:228-233.
21. Dawson J, Sedgewick AD, Edwards JC, Lees P. A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Int J Tissue React 1991; 13:171-185.
22. Fischman AJ, Rauh D, Solomon H, et al. In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. J Nucl Med 1993;34:2130 2134.
23. Babich JW, Fischman AJ. Effect of co-ligand on the biodistribution of WmTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides. Nucl Med Biol 1995;22: 25-30.